Allogeneic Stem Cell Transplant for CLL

Clinical trial NCT01629511 · TERMINATED

Trial details

NCT number: NCT01629511
Sponsor: M.D. Anderson Cancer Center
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Allogeneic Hematopoietic Stem Cell Transplantation Recipient Chronic Lymphocytic Leukemia Prolymphocytic Leukemia Richter Syndrome

Start date: 2012-11-21
Primary completion: 2018-04-25
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.